Global Hypertension RDN Therapy Supply, Demand and Key Producers, 2024-2030

Page: 127

Published Date: 21 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Hypertension RDN Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Renal denervation (also called renal ablation) is a minimally invasive, investigational procedure to treat hypertension (high blood pressure) that hasn't improved with other treatments. This type of hypertension is called resistant hypertension
This report studies the global Hypertension RDN Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hypertension RDN Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hypertension RDN Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hypertension RDN Therapy total market, 2019-2030, (USD Million)
Global Hypertension RDN Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Hypertension RDN Therapy total market, key domestic companies and share, (USD Million)
Global Hypertension RDN Therapy revenue by player and market share 2019-2024, (USD Million)
Global Hypertension RDN Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global Hypertension RDN Therapy total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Hypertension RDN Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, ReCor Medical, Sonivies, Covidien, Boston Scientific, Johnson & Johnson, Terumo Corporation, Angiocare and Shanghai Golden Leaf Med Tec, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hypertension RDN Therapy market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Hypertension RDN Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Hypertension RDN Therapy Market, Segmentation by Type
r-Renal Denervation(rRDN)
u-Renal Denervation(uRDN)

Global Hypertension RDN Therapy Market, Segmentation by Application
Hospital
Clinic
Others

Companies Profiled:
Medtronic
ReCor Medical
Sonivies
Covidien
Boston Scientific
Johnson & Johnson
Terumo Corporation
Angiocare
Shanghai Golden Leaf Med Tec
Shanghai Bio-Heart Biological Technology
Xinmai Medical Equipment
Microport Ep Medtech
Cryofocus Medtech

Key Questions Answered
1. How big is the global Hypertension RDN Therapy market?
2. What is the demand of the global Hypertension RDN Therapy market?
3. What is the year over year growth of the global Hypertension RDN Therapy market?
4. What is the total value of the global Hypertension RDN Therapy market?
5. Who are the major players in the global Hypertension RDN Therapy market?

Table of Contents

1 Supply Summary
    1.1 Hypertension RDN Therapy Introduction
    1.2 World Hypertension RDN Therapy Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Hypertension RDN Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Hypertension RDN Therapy Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Hypertension RDN Therapy Market Size (2019-2030)
        1.3.3 China Hypertension RDN Therapy Market Size (2019-2030)
        1.3.4 Europe Hypertension RDN Therapy Market Size (2019-2030)
        1.3.5 Japan Hypertension RDN Therapy Market Size (2019-2030)
        1.3.6 South Korea Hypertension RDN Therapy Market Size (2019-2030)
        1.3.7 ASEAN Hypertension RDN Therapy Market Size (2019-2030)
        1.3.8 India Hypertension RDN Therapy Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Hypertension RDN Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Hypertension RDN Therapy Major Market Trends

2 Demand Summary
    2.1 World Hypertension RDN Therapy Consumption Value (2019-2030)
    2.2 World Hypertension RDN Therapy Consumption Value by Region
        2.2.1 World Hypertension RDN Therapy Consumption Value by Region (2019-2024)
        2.2.2 World Hypertension RDN Therapy Consumption Value Forecast by Region (2025-2030)
    2.3 United States Hypertension RDN Therapy Consumption Value (2019-2030)
    2.4 China Hypertension RDN Therapy Consumption Value (2019-2030)
    2.5 Europe Hypertension RDN Therapy Consumption Value (2019-2030)
    2.6 Japan Hypertension RDN Therapy Consumption Value (2019-2030)
    2.7 South Korea Hypertension RDN Therapy Consumption Value (2019-2030)
    2.8 ASEAN Hypertension RDN Therapy Consumption Value (2019-2030)
    2.9 India Hypertension RDN Therapy Consumption Value (2019-2030)

3 World Hypertension RDN Therapy Companies Competitive Analysis
    3.1 World Hypertension RDN Therapy Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Hypertension RDN Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Hypertension RDN Therapy in 2023
        3.2.3 Global Concentration Ratios (CR8) for Hypertension RDN Therapy in 2023
    3.3 Hypertension RDN Therapy Company Evaluation Quadrant
    3.4 Hypertension RDN Therapy Market: Overall Company Footprint Analysis
        3.4.1 Hypertension RDN Therapy Market: Region Footprint
        3.4.2 Hypertension RDN Therapy Market: Company Product Type Footprint
        3.4.3 Hypertension RDN Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Hypertension RDN Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Hypertension RDN Therapy Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Hypertension RDN Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Hypertension RDN Therapy Consumption Value Comparison
        4.2.1 United States VS China: Hypertension RDN Therapy Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Hypertension RDN Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Hypertension RDN Therapy Companies and Market Share, 2019-2024
        4.3.1 United States Based Hypertension RDN Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Hypertension RDN Therapy Revenue, (2019-2024)
    4.4 China Based Companies Hypertension RDN Therapy Revenue and Market Share, 2019-2024
        4.4.1 China Based Hypertension RDN Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Hypertension RDN Therapy Revenue, (2019-2024)
    4.5 Rest of World Based Hypertension RDN Therapy Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Hypertension RDN Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Hypertension RDN Therapy Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Hypertension RDN Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 r-Renal Denervation(rRDN)
        5.2.2 u-Renal Denervation(uRDN)
    5.3 Market Segment by Type
        5.3.1 World Hypertension RDN Therapy Market Size by Type (2019-2024)
        5.3.2 World Hypertension RDN Therapy Market Size by Type (2025-2030)
        5.3.3 World Hypertension RDN Therapy Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Hypertension RDN Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Hypertension RDN Therapy Market Size by Application (2019-2024)
        6.3.2 World Hypertension RDN Therapy Market Size by Application (2025-2030)
        6.3.3 World Hypertension RDN Therapy Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Medtronic
        7.1.1 Medtronic Details
        7.1.2 Medtronic Major Business
        7.1.3 Medtronic Hypertension RDN Therapy Product and Services
        7.1.4 Medtronic Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Medtronic Recent Developments/Updates
        7.1.6 Medtronic Competitive Strengths & Weaknesses
    7.2 ReCor Medical
        7.2.1 ReCor Medical Details
        7.2.2 ReCor Medical Major Business
        7.2.3 ReCor Medical Hypertension RDN Therapy Product and Services
        7.2.4 ReCor Medical Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 ReCor Medical Recent Developments/Updates
        7.2.6 ReCor Medical Competitive Strengths & Weaknesses
    7.3 Sonivies
        7.3.1 Sonivies Details
        7.3.2 Sonivies Major Business
        7.3.3 Sonivies Hypertension RDN Therapy Product and Services
        7.3.4 Sonivies Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Sonivies Recent Developments/Updates
        7.3.6 Sonivies Competitive Strengths & Weaknesses
    7.4 Covidien
        7.4.1 Covidien Details
        7.4.2 Covidien Major Business
        7.4.3 Covidien Hypertension RDN Therapy Product and Services
        7.4.4 Covidien Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Covidien Recent Developments/Updates
        7.4.6 Covidien Competitive Strengths & Weaknesses
    7.5 Boston Scientific
        7.5.1 Boston Scientific Details
        7.5.2 Boston Scientific Major Business
        7.5.3 Boston Scientific Hypertension RDN Therapy Product and Services
        7.5.4 Boston Scientific Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Boston Scientific Recent Developments/Updates
        7.5.6 Boston Scientific Competitive Strengths & Weaknesses
    7.6 Johnson & Johnson
        7.6.1 Johnson & Johnson Details
        7.6.2 Johnson & Johnson Major Business
        7.6.3 Johnson & Johnson Hypertension RDN Therapy Product and Services
        7.6.4 Johnson & Johnson Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Johnson & Johnson Recent Developments/Updates
        7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.7 Terumo Corporation
        7.7.1 Terumo Corporation Details
        7.7.2 Terumo Corporation Major Business
        7.7.3 Terumo Corporation Hypertension RDN Therapy Product and Services
        7.7.4 Terumo Corporation Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Terumo Corporation Recent Developments/Updates
        7.7.6 Terumo Corporation Competitive Strengths & Weaknesses
    7.8 Angiocare
        7.8.1 Angiocare Details
        7.8.2 Angiocare Major Business
        7.8.3 Angiocare Hypertension RDN Therapy Product and Services
        7.8.4 Angiocare Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Angiocare Recent Developments/Updates
        7.8.6 Angiocare Competitive Strengths & Weaknesses
    7.9 Shanghai Golden Leaf Med Tec
        7.9.1 Shanghai Golden Leaf Med Tec Details
        7.9.2 Shanghai Golden Leaf Med Tec Major Business
        7.9.3 Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Product and Services
        7.9.4 Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Shanghai Golden Leaf Med Tec Recent Developments/Updates
        7.9.6 Shanghai Golden Leaf Med Tec Competitive Strengths & Weaknesses
    7.10 Shanghai Bio-Heart Biological Technology
        7.10.1 Shanghai Bio-Heart Biological Technology Details
        7.10.2 Shanghai Bio-Heart Biological Technology Major Business
        7.10.3 Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Product and Services
        7.10.4 Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Shanghai Bio-Heart Biological Technology Recent Developments/Updates
        7.10.6 Shanghai Bio-Heart Biological Technology Competitive Strengths & Weaknesses
    7.11 Xinmai Medical Equipment
        7.11.1 Xinmai Medical Equipment Details
        7.11.2 Xinmai Medical Equipment Major Business
        7.11.3 Xinmai Medical Equipment Hypertension RDN Therapy Product and Services
        7.11.4 Xinmai Medical Equipment Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Xinmai Medical Equipment Recent Developments/Updates
        7.11.6 Xinmai Medical Equipment Competitive Strengths & Weaknesses
    7.12 Microport Ep Medtech
        7.12.1 Microport Ep Medtech Details
        7.12.2 Microport Ep Medtech Major Business
        7.12.3 Microport Ep Medtech Hypertension RDN Therapy Product and Services
        7.12.4 Microport Ep Medtech Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Microport Ep Medtech Recent Developments/Updates
        7.12.6 Microport Ep Medtech Competitive Strengths & Weaknesses
    7.13 Cryofocus Medtech
        7.13.1 Cryofocus Medtech Details
        7.13.2 Cryofocus Medtech Major Business
        7.13.3 Cryofocus Medtech Hypertension RDN Therapy Product and Services
        7.13.4 Cryofocus Medtech Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Cryofocus Medtech Recent Developments/Updates
        7.13.6 Cryofocus Medtech Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Hypertension RDN Therapy Industry Chain
    8.2 Hypertension RDN Therapy Upstream Analysis
    8.3 Hypertension RDN Therapy Midstream Analysis
    8.4 Hypertension RDN Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Hypertension RDN Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Hypertension RDN Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Hypertension RDN Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Hypertension RDN Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Hypertension RDN Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Hypertension RDN Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Hypertension RDN Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Hypertension RDN Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Hypertension RDN Therapy Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Hypertension RDN Therapy Players in 2023
    Table 12. World Hypertension RDN Therapy Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Hypertension RDN Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Hypertension RDN Therapy Player
    Table 15. Hypertension RDN Therapy Market: Company Product Type Footprint
    Table 16. Hypertension RDN Therapy Market: Company Product Application Footprint
    Table 17. Hypertension RDN Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Hypertension RDN Therapy Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Hypertension RDN Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Hypertension RDN Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Hypertension RDN Therapy Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Hypertension RDN Therapy Revenue Market Share (2019-2024)
    Table 23. China Based Hypertension RDN Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Hypertension RDN Therapy Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Hypertension RDN Therapy Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Hypertension RDN Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Hypertension RDN Therapy Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Hypertension RDN Therapy Revenue Market Share (2019-2024)
    Table 29. World Hypertension RDN Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Hypertension RDN Therapy Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Hypertension RDN Therapy Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Hypertension RDN Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Hypertension RDN Therapy Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Hypertension RDN Therapy Market Size by Application (2025-2030) & (USD Million)
    Table 35. Medtronic Basic Information, Area Served and Competitors
    Table 36. Medtronic Major Business
    Table 37. Medtronic Hypertension RDN Therapy Product and Services
    Table 38. Medtronic Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Medtronic Recent Developments/Updates
    Table 40. Medtronic Competitive Strengths & Weaknesses
    Table 41. ReCor Medical Basic Information, Area Served and Competitors
    Table 42. ReCor Medical Major Business
    Table 43. ReCor Medical Hypertension RDN Therapy Product and Services
    Table 44. ReCor Medical Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. ReCor Medical Recent Developments/Updates
    Table 46. ReCor Medical Competitive Strengths & Weaknesses
    Table 47. Sonivies Basic Information, Area Served and Competitors
    Table 48. Sonivies Major Business
    Table 49. Sonivies Hypertension RDN Therapy Product and Services
    Table 50. Sonivies Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Sonivies Recent Developments/Updates
    Table 52. Sonivies Competitive Strengths & Weaknesses
    Table 53. Covidien Basic Information, Area Served and Competitors
    Table 54. Covidien Major Business
    Table 55. Covidien Hypertension RDN Therapy Product and Services
    Table 56. Covidien Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Covidien Recent Developments/Updates
    Table 58. Covidien Competitive Strengths & Weaknesses
    Table 59. Boston Scientific Basic Information, Area Served and Competitors
    Table 60. Boston Scientific Major Business
    Table 61. Boston Scientific Hypertension RDN Therapy Product and Services
    Table 62. Boston Scientific Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Boston Scientific Recent Developments/Updates
    Table 64. Boston Scientific Competitive Strengths & Weaknesses
    Table 65. Johnson & Johnson Basic Information, Area Served and Competitors
    Table 66. Johnson & Johnson Major Business
    Table 67. Johnson & Johnson Hypertension RDN Therapy Product and Services
    Table 68. Johnson & Johnson Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Johnson & Johnson Recent Developments/Updates
    Table 70. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 71. Terumo Corporation Basic Information, Area Served and Competitors
    Table 72. Terumo Corporation Major Business
    Table 73. Terumo Corporation Hypertension RDN Therapy Product and Services
    Table 74. Terumo Corporation Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Terumo Corporation Recent Developments/Updates
    Table 76. Terumo Corporation Competitive Strengths & Weaknesses
    Table 77. Angiocare Basic Information, Area Served and Competitors
    Table 78. Angiocare Major Business
    Table 79. Angiocare Hypertension RDN Therapy Product and Services
    Table 80. Angiocare Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Angiocare Recent Developments/Updates
    Table 82. Angiocare Competitive Strengths & Weaknesses
    Table 83. Shanghai Golden Leaf Med Tec Basic Information, Area Served and Competitors
    Table 84. Shanghai Golden Leaf Med Tec Major Business
    Table 85. Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Product and Services
    Table 86. Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Shanghai Golden Leaf Med Tec Recent Developments/Updates
    Table 88. Shanghai Golden Leaf Med Tec Competitive Strengths & Weaknesses
    Table 89. Shanghai Bio-Heart Biological Technology Basic Information, Area Served and Competitors
    Table 90. Shanghai Bio-Heart Biological Technology Major Business
    Table 91. Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Product and Services
    Table 92. Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Shanghai Bio-Heart Biological Technology Recent Developments/Updates
    Table 94. Shanghai Bio-Heart Biological Technology Competitive Strengths & Weaknesses
    Table 95. Xinmai Medical Equipment Basic Information, Area Served and Competitors
    Table 96. Xinmai Medical Equipment Major Business
    Table 97. Xinmai Medical Equipment Hypertension RDN Therapy Product and Services
    Table 98. Xinmai Medical Equipment Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Xinmai Medical Equipment Recent Developments/Updates
    Table 100. Xinmai Medical Equipment Competitive Strengths & Weaknesses
    Table 101. Microport Ep Medtech Basic Information, Area Served and Competitors
    Table 102. Microport Ep Medtech Major Business
    Table 103. Microport Ep Medtech Hypertension RDN Therapy Product and Services
    Table 104. Microport Ep Medtech Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Microport Ep Medtech Recent Developments/Updates
    Table 106. Cryofocus Medtech Basic Information, Area Served and Competitors
    Table 107. Cryofocus Medtech Major Business
    Table 108. Cryofocus Medtech Hypertension RDN Therapy Product and Services
    Table 109. Cryofocus Medtech Hypertension RDN Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 110. Global Key Players of Hypertension RDN Therapy Upstream (Raw Materials)
    Table 111. Hypertension RDN Therapy Typical Customers
List of Figure
    Figure 1. Hypertension RDN Therapy Picture
    Figure 2. World Hypertension RDN Therapy Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Hypertension RDN Therapy Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Hypertension RDN Therapy Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Hypertension RDN Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Hypertension RDN Therapy Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Hypertension RDN Therapy Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Hypertension RDN Therapy Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Hypertension RDN Therapy Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Hypertension RDN Therapy Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Hypertension RDN Therapy Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Hypertension RDN Therapy Revenue (2019-2030) & (USD Million)
    Figure 13. Hypertension RDN Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Hypertension RDN Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Hypertension RDN Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Hypertension RDN Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Hypertension RDN Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Hypertension RDN Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Hypertension RDN Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Hypertension RDN Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Hypertension RDN Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Hypertension RDN Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Hypertension RDN Therapy by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Hypertension RDN Therapy Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Hypertension RDN Therapy Markets in 2023
    Figure 27. United States VS China: Hypertension RDN Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Hypertension RDN Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Hypertension RDN Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Hypertension RDN Therapy Market Size Market Share by Type in 2023
    Figure 31. r-Renal Denervation(rRDN)
    Figure 32. u-Renal Denervation(uRDN)
    Figure 33. World Hypertension RDN Therapy Market Size Market Share by Type (2019-2030)
    Figure 34. World Hypertension RDN Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Hypertension RDN Therapy Market Size Market Share by Application in 2023
    Figure 36. Hospital
    Figure 37. Clinic
    Figure 38. Others
    Figure 39. Hypertension RDN Therapy Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Medtronic
ReCor Medical
Sonivies
Covidien
Boston Scientific
Johnson & Johnson
Terumo Corporation
Angiocare
Shanghai Golden Leaf Med Tec
Shanghai Bio-Heart Biological Technology
Xinmai Medical Equipment
Microport Ep Medtech
Cryofocus Medtech

Related Reports

Global Hypertension RDN Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Hypertension RDN Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 16 May 2023

date Medical Care

According to our (Global Info Research) latest study, the global Hypertension RDN Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Hypertension RDN Therapy Supply, Demand and Key Producers, 2023-2029

Global Hypertension RDN Therapy Supply, Demand and Key Producers, 2023-2029

date 16 May 2023

date Medical Care

The global Hypertension RDN Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Hypertension RDN Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Hypertension RDN Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 16 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Hypertension RDN Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Hypertension RDN Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>